Analyst Price Targets — OMCL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 31, 2026 11:05 am | — | KeyBanc | $65.00 | $37.11 | TheFly | Omnicell price target lowered to $65 from $70 at KeyBanc |
| July 31, 2026 10:57 am | Stan Berenshteyn | Wells Fargo | $50.00 | $37.11 | TheFly | Omnicell price target lowered to $50 from $55 at Wells Fargo |
| April 29, 2026 1:29 pm | — | Craig-Hallum | $55.00 | $44.45 | TheFly | Omnicell price target raised to $55 from $53 at Craig-Hallum |
| April 28, 2026 5:10 pm | — | KeyBanc | $70.00 | $44.31 | TheFly | Omnicell price target raised to $70 from $60 at KeyBanc |
| March 13, 2026 11:14 am | — | UBS | $60.00 | $35.10 | StreetInsider | Omnicell (OMCL) Reiterated at Buy by Benchmark After Investor, CEO Meet |
| February 6, 2026 11:55 am | — | Piper Sandler | $49.00 | $39.08 | TheFly | Omnicell price target lowered to $49 from $63 at Piper Sandler |
| January 16, 2026 10:15 am | — | UBS | $53.00 | $50.98 | StreetInsider | Omnicell (OMCL) PT Raised to $53 at BofA Securities |
| January 7, 2026 10:47 pm | — | KeyBanc | $60.00 | $47.45 | TheFly | Omnicell upgraded to Overweight from Sector Weight at KeyBanc |
| January 5, 2026 1:08 pm | — | Wells Fargo | $52.00 | $45.64 | TheFly | Omnicell price target raised to $52 from $43 at Wells Fargo |
| August 11, 2025 12:26 pm | Jessica Tassan | Piper Sandler | $55.00 | $31.11 | StreetInsider | Omnicell (OMCL) PT Lowered to $55 at Piper Sandler Despite Guide Raise |
Latest News for OMCL
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The disposal comprised 6,753 shares representing a total transaction value of ~$250,000. The transaction reduced the insider's direct equity holdings by 4%.
Bank of America Corp DE raised its holdings in Omnicell, Inc. (NASDAQ: OMCL) by 31.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 580,875 shares of the company's stock after acquiring an additional 138,537 shares during the
OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.